SIPA1L1-AS1: A Potential Drug Target and Biomarker (G102724015)

Target Name: SIPA1L1-AS1

NCBI ID: G102724015

SIPA1L1-AS1

Other Name(s): SIPA1L1 antisense RNA 1, transcript variant X1 | SIPA1L1 antisense RNA 1 | SIPA1L1-AS1 variant X1

SIPA1L1-AS1: A Potential Drug Target and Biomarker

SIPA1L1-AS1, also known as SIPA1L1 antisense RNA 1, is a non-coding RNA molecule that has been shown to play a critical role in various cellular processes. The molecule has been identified as a potential drug target and biomarker, with a wide range of potential applications in the pharmaceutical and biomedical industries.

SIPA1L1-AS1 functions as an antisense RNA, which means it competes with the mRNA for translation into protein. In this process, the molecule can interact with specific target proteins, preventing them from being translated into functional proteins. This mechanism of action is similar to that of other RNA molecules known as post-transcriptional repressors, such as microRNAs.

SIPA1L1-AS1 has been shown to play a crucial role in the regulation of cellular processes that are important for human health, including cell growth, apoptosis, and inflammation. For example, studies have shown that SIPA1L1-AS1 is involved in the regulation of cell cycle progression, and that it can induce apoptosis in cancer cells.

In addition to its role in cellular processes, SIPA1L1-AS1 has also been shown to be a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that SIPA1L1-AS1 is downregulated in various types of cancer, and that it can be used as a diagnostic marker for these diseases.

SIPA1L1-AS1 has also been shown to have a strong positive correlation with disease severity in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that SIPA1L1-AS1 may be a useful biomarker for these diseases, and that it may play a role in the development and progression of these conditions.

In addition to its potential as a drug target and biomarker, SIPA1L1-AS1 also has a role in the regulation of cellular signaling pathways. Studies have shown that the molecule can interact with various signaling molecules, including NF-kappa1, and that it can modulate their activity. This suggests that SIPA1L1-AS1 may be a useful target for drugs that are designed to modulate cellular signaling pathways.

Overall, SIPA1L1-AS1 is a promising candidate for a variety of drug targets and biomarkers. Further research is needed to fully understand its role in cellular processes and its potential applications in the pharmaceutical and biomedical industries.

Protein Name: SIPA1L1 Antisense RNA 1

The "SIPA1L1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SIPA1L1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets